Furthermore, SPP1+ TAMs in PHT demonstrate enhanced angiogenic ability and inhibit lymphocyte migration (Figure S5E, Table S10, Supporting Information), supporting their role in promoting tumor progression. The gene discussed is SPP1; the disease is neoplasm.